EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of CXCR5, PD‐1 and ICOS on B‐cell responses and relevance to myasthenia gravis

Merve Çebi iD, Arman Çakar iD, Hacer Durmuş iD, Yeşim Parman iD, Güher Saruhan-Direskeneli iD

Clinical & Translational Immunology · 2026-06 · 15 (6)

DOI: 10.1002/cti2.70112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Translational Immunology, online erschienen am 21.06.2026. Verfasst von Merve Çebi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Istanbul Medical Faculty Istanbul University Istanbul Turkey. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, Istanbul Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

T follicular helper (Tfh) cells regulate B‐cell responses within germinal centres primarily via programmed cell death protein 1 (PD‐1) and inducible T‐cell costimulator (ICOS), whereas CXC chemokine receptor type 5 (CXCR5)‐negative T peripheral helper (Tph) cells provide similar support extra‐follicularly. Both subsets contribute to the pathogenesis of acetylcholine receptor‐antibody‐positive myasthenia gravis (AChR‐MG). This study investigated the roles of PD‐1, ICOS and CXCR5 in T‐cell‐mediated B‐cell activation to identify therapeutic targets for MG.

Methods

CD4 T cells from 10 healthy controls and six untreated AChR‐MG patients were sorted by CXCR5, PD‐1 and ICOS expression, stimulated with anti‐CD3/CD28, and co‐cultured with autologous CD19 B cells. Plasmablast differentiation, total AChR‐IgG and cytokine productions were measured.

Results

In healthy donors, PD‐1 + or ICOS + Tph cells modestly enhanced plasmablasts and IgG production, while CXCR5 + Tfh cells co‐expressing PD‐1 or ICOS induced significantly stronger B‐cell responses. In AChR‐MG patients, PD‐1 expressing T cells promoted plasmablasts, antibody production and cytokine secretion regardless of CXCR5, with amplified effects in CXCR5 + co‐cultures.

Conclusions

PD‐1 expression on CD4 + T cells is associated with increased B‐cell helper capacity. This effect is more pronounced in Tfh‐related contexts and is linked to dysregulated humoral immune responses in MG. PD‐1 appears to play a central role in the pathogenesis of MG, primarily through Tfh cell activity.

Schlagwörter

Stichwörter der Autor:innen

CXCR5ICOSPD‐1T follicular helper cellsT peripheral helper cellsmyasthenia gravis

Autor:innen und Institutionen

  • Department of Physiology, Istanbul Medical Faculty Istanbul University Istanbul Turkey.
  • Present address: M Çebi, Department of Medical Biology School of Medicine, Recep Tayyip Erdoğan University Rize Turkey.
  • Department of Neurology, Istanbul Medical Faculty Istanbul University Istanbul Turkey.

ORCID-Profile: Merve Çebi, Arman Çakar, Hacer Durmuş, Yeşim Parman, Güher Saruhan-Direskeneli

Förderung

  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
  • Istanbul Üniversitesi

Zitieren

APA

Çebi, M., Çakar, A., Durmuş, H., Parman, Y., & Saruhan-Direskeneli, G. (2026). Effect of CXCR5, PD‐1 and ICOS on B‐cell responses and relevance to myasthenia gravis. Clinical & Translational Immunology, 15(6). https://doi.org/10.1002/cti2.70112

Vancouver

Çebi M, Çakar A, Durmuş H, Parman Y, Saruhan-Direskeneli G. Effect of CXCR5, PD‐1 and ICOS on B‐cell responses and relevance to myasthenia gravis. Clinical & Translational Immunology. 2026;15(6). doi:10.1002/cti2.70112

BibTeX
@article{ebi2026,
  author = {Çebi, Merve and Çakar, Arman and Durmuş, Hacer and Parman, Yeşim and Saruhan-Direskeneli, Güher},
  title = {Effect of CXCR5, PD‐1 and ICOS on B‐cell responses and relevance to myasthenia gravis},
  journal = {Clinical & Translational Immunology},
  year = {2026},
  volume = {15},
  number = {6},
  doi = {10.1002/cti2.70112}
}
Kostenlos starten →